Parametric Portfolio Associates’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Parametric Portfolio Associates’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$8.67M	Buy	73,100 +18,226	+33%	+$2.27M	﹤0.01%	1465
2021 Q4	$7.56M	Sell	54,874 -23,242	-30%	-$2.96M	﹤0.01%	1577
2021 Q3	$10.9M	Buy	78,116 +31,913	+69%	+$3.98M	0.01%	1299
2021 Q2	$4.49M	Buy	46,203 +28,171	+156%	+$2.29M	﹤0.01%	1917
2021 Q1	$1.23M	Sell	18,032 -11,559	-39%	-$935K	﹤0.01%	3066
2020 Q4	$2.54M	Buy	29,591 +2,948	+11%	+$250K	﹤0.01%	2510
2020 Q3	$1.73M	Sell	26,643 -2,562	-9%	-$168K	﹤0.01%	2595
2020 Q2	$2.13M	Buy	29,205 +14,287	+96%	+$760K	﹤0.01%	2461
2020 Q1	$508K	Buy	14,918 +284	+2%	+$13K	﹤0.01%	3151
2019 Q4	$797K	Buy	14,634 +6,657	+83%	+$330K	﹤0.01%	3168
2019 Q3	$333K	Sell	7,977 -18,402	-70%	-$777K	﹤0.01%	3492
2019 Q2	$1.16M	Buy	26,379 +3,116	+13%	+$176K	﹤0.01%	2981
2019 Q1	$1.2M	Buy	+23,263	New	+$1.01M	﹤0.01%	2938
2017 Q4	–	Sell	-17,817	Closed	-$666K	–	4033
2017 Q3	$666K	Buy	+17,817	New	+$540K	﹤0.01%	3265

Other funds holding BHVN

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Parametric Portfolio Associates's BHVN Position: Q1 2022 in Review

Parametric Portfolio Associates increased its Biohaven Pharmaceutical Holding Company Ltd. (BHVN) stake by 33% in Q1 2022, buying an estimated $2.27M and bringing the position to 73,100 shares worth $8.67M. The position accounts for ﹤0.01% of the portfolio, ranked #1465.

Parametric Portfolio Associates first reported a position in BHVN in Q3 2017 and has held it in 14 quarters since. The position peaked at $10.9M in Q3 2021. 307 funds tracked by Wall St. Rank hold BHVN as of Q1 2022.

Parametric Portfolio Associates held 73,100 shares of Biohaven Pharmaceutical Holding Company Ltd. worth $8.67M as of Q1 2022.
Parametric Portfolio Associates bought 18,226 Biohaven Pharmaceutical Holding Company Ltd. shares in Q1 2022, an estimated $2.27M.
Biohaven Pharmaceutical Holding Company Ltd. made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #1465 holding.
Parametric Portfolio Associates first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q3 2017 and has held it in 14 quarters since.
Parametric Portfolio Associates's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $10.9M in Q3 2021.
307 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.